Lipocine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lipocine using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.44 | $-0.48 | 8.33 % |
Jun 2024 | 2024-08-08 | $-0.56 | $-0.78 | 28.2 % |
Mar 2024 | 2024-05-09 | $0.66 | $-0.68 | 197.1 % |
Dec 2023 | 2024-03-07 | $-0.42 | $-0.47 | 10.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $0 | $150.00K | -100.0 % |
Jun 2024 | 2024-08-08 | $89.57K | $290.00K | -69.1 % |
Sep 2023 | 2023-11-08 | $-3.12M | $470.00K | -764.3 % |
Jun 2023 | 2023-08-10 | $0 | $280.00K | -100.0 % |
Lipocine ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
Lipocine ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.44, which beat the estimate of $-0.48.
Lipocine ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.